Pharma Journalist 8916 posts 0 comments

Vaxalto Biotherapeutics, Inc. (www.vaxalto.com), a pre-clinical stage biotechnology company focused on developing and commercializing novel engineered immunotherapeutic oncolytic…
Read More...

Cerecor Inc. a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare and orphan diseases, announced final efficacy data…
Read More...

WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, announced that it has…
Read More...

ObvioHealth, a global virtual research organization or VRO, announced the launch of a hybrid clinical trial for the treatment of COVID-19, using an innovative study design with digital…
Read More...

Merck, known as MSD outside the United States and Canada, announced it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of…
Read More...

Oscotec Inc. the Korean drug development company, and Beactica Therapeutics AB, the Swedish drug discovery company, announced a new research development and licensing agreement. Oscotec…
Read More...

Iktos announced the application of Iktos Artificial Intelligence technology for de novo design to selected Pfizer small-molecule discovery programs. Over the last few years,…
Read More...

SMi reports: Exclusive Co-Chair letter invitation released for the upcoming Pre-Filled Syringes West Coast 2021 SMi are delighted to have Tina Rees, Associate Director, Regeneron…
Read More...

Phio Pharmaceuticals Corp. a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL) therapeutic…
Read More...

HitGen announced that it has entered into a drug discovery research collaboration with UPPTHERA Inc. to identify small molecule Hits against previous known-to-be undruggable targets and…
Read More...